They found that miR-144 was significantly down-regulated in CCA tissues and suggested that miR-144 via targeting of LIS1 and decrease of AKT pathway activity may be a primary inhibitor of CCA cell proliferation and invasion [100]. The gene discussed is AKT1; the disease is cholangiocarcinoma.